Ai, X., Zhang, Y. Y., Zhang, T., Yi, T., Li, M., Yao, W., Han, L., Sun, L., Liu, A., Mei, Q., Han, G., Zhang, Z., Li, Y., Li, L., Zheng, L., Fang, Y., Luo, Y., Wu, J. J., Lu, S. (2025). A phase 2 dose expansion study of ZG006, a trispecific T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with advanced small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8007